NCT00061347View on ClinicalTrials.gov

Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 23, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

April 19, 2018

Conditions
Prostate CancerCancer
Interventions
PROCEDURE

Fiducial marker placement

Placement of fidicual markers under MRI guidance for localization of radiaiton treatment

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00061347 - Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment | Biotech Hunter | Biotech Hunter